Identifying patients for safe early hospital discharge following st elevation myocardial infarction

Musa A Sharkawi1,2, Andreas Filippaios3, Saurabh S Dani4

  • 1Department of Cardiovascular Medicine, Hartford Hospital, Hartford, Connecticut.

Insights

The CADILLAC risk score effectively identifies low-risk patients with ST-elevation myocardial infarction (STEMI) for safe early discharge. This stratification minimizes adverse events and mortality, making earlier hospital release feasible for selected individuals post-PCI.

Area of Science:

  • Cardiology
  • Clinical Risk Stratification
  • Acute Coronary Syndromes

Background:

  • Hospitalization for ST-elevation myocardial infarction (STEMI) is standard for monitoring complications.
  • The optimal duration of hospital stay post-STEMI remains unclear.
  • The safety of early discharge (before 72 hours) for low-risk STEMI patients is not well-established.

Purpose of the Study:

  • To evaluate the effectiveness of the CADILLAC risk score in stratifying patients with STEMI for early discharge.
  • To determine if low-risk stratification by CADILLAC score predicts favorable outcomes.
  • To assess the safety and feasibility of early discharge for selected STEMI patients post-primary PCI.

Main Methods:

  • Retrospective analysis of STEMI patients who underwent successful percutaneous coronary intervention (PCI).
  • Stratification of patients into low-risk (n=123) and intermediate-to-high-risk (n=105) groups using the CADILLAC risk score.
  • Primary outcome: adverse clinical events from day 3 onwards. Secondary outcomes: early adverse events (day 1) and mortality at 30 days and 1 year.

Main Results:

  • Low-risk patients experienced significantly fewer major adverse clinical events at day 3 or later (0% vs. 11.4%, P=0.0002).
  • One-year mortality was substantially lower in the low-risk group (0% vs. 4.8%, P=0.02).
  • Low-risk patients had fewer cardiovascular events within the first 24 hours (3.3% vs. 13.3%, P=0.006).

Conclusions:

  • The CADILLAC risk score is effective for identifying low-risk STEMI patients suitable for early discharge after successful primary PCI.
  • Early discharge appears safe for selected low-risk STEMI patients, with significantly reduced adverse events.
  • Non-critical care monitoring may be a feasible option for these selected patients post-primary PCI.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
374
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
357
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
286
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
611
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
941